1 |
HDAC6
| 4件: Neutrophil extracellular trap formation Neutrophil extracellular trap formation 💬, Amyotrophic lateral sclerosis 💬, Alcoholism 💬, Viral carcinogenesis 💬 | D06320
D06320
|
Vorinostat
| 3件: 19 19, 75, 96 |
2 |
HDAC5
| 5件: Apelin signaling pathway Apelin signaling pathway 💬, Neutrophil extracellular trap formation 💬, Alcoholism 💬, Viral carcinogenesis 💬, MicroRNAs in cancer 💬 | D06320
D06320
|
Vorinostat
| 3件: 19 19, 75, 96 |
3 |
CHRM1
| 8件: Calcium signaling pathway Calcium signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, PI3K-Akt signaling pathway 💬, Cholinergic synapse 💬, Regulation of actin cytoskeleton 💬, Alzheimer disease 💬, Pathways of neurodegeneration - multiple diseases 💬 | D00397
D00397
|
Tropicamide
| 3件: 6 6, 13, 19 |
4 |
CHRM2
| 6件: Calcium signaling pathway Calcium signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, PI3K-Akt signaling pathway 💬, Cholinergic synapse 💬, Regulation of actin cytoskeleton 💬 | D00397
D00397
|
Tropicamide
| 3件: 6 6, 13, 19 |
5 |
CHRM3
| 11件: Calcium signaling pathway Calcium signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Cholinergic synapse 💬, Taste transduction 💬, Regulation of actin cytoskeleton 💬, Insulin secretion 💬, Salivary secretion 💬, Gastric acid secretion 💬, Pancreatic secretion 💬, Alzheimer disease 💬, Pathways of neurodegeneration - multiple diseases 💬 | D00397
D00397
|
Tropicamide
| 3件: 6 6, 13, 19 |
6 |
CHRM4
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Cholinergic synapse 💬, Regulation of actin cytoskeleton 💬 | D00397
D00397
|
Tropicamide
| 3件: 6 6, 13, 19 |
7 |
CHRM5
| 6件: Calcium signaling pathway Calcium signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Cholinergic synapse 💬, Regulation of actin cytoskeleton 💬, Alzheimer disease 💬, Pathways of neurodegeneration - multiple diseases 💬 | D00397
D00397
|
Tropicamide
| 3件: 6 6, 13, 19 |
8 |
TPP1
| 1件: Lysosome Lysosome 💬 | D10813
D10813
|
Cerliponase alfa
| 1件: 19 19 |
9 |
CSF3R
| 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬, PI3K-Akt signaling pathway 💬, JAK-STAT signaling pathway 💬, Hematopoietic cell lineage 💬, Pathways in cancer 💬 | D03247
D03247
|
Lenograstim
| 7件: 2 2, 13, 16, 18, 19, 57, 65 |
10 |
ACE
| 6件: Renin-angiotensin system Renin-angiotensin system 💬, Renin secretion 💬, Chagas disease 💬, Coronavirus disease - COVID-19 💬, Hypertrophic cardiomyopathy 💬, Diabetic cardiomyopathy 💬 | D00362
D00362
|
Lisinopril
| 7件: 19 19, 46, 49, 66, 67, 113, 222 |
11 |
ACE
| 6件: Renin-angiotensin system Renin-angiotensin system 💬, Renin secretion 💬, Chagas disease 💬, Coronavirus disease - COVID-19 💬, Hypertrophic cardiomyopathy 💬, Diabetic cardiomyopathy 💬 | D00459
D00459
|
Quinapril
| 1件: 19 19 |
12 |
ACE
| 6件: Renin-angiotensin system Renin-angiotensin system 💬, Renin secretion 💬, Chagas disease 💬, Coronavirus disease - COVID-19 💬, Hypertrophic cardiomyopathy 💬, Diabetic cardiomyopathy 💬 | D00621
D00621
|
Enalapril
| 6件: 19 19, 46, 66, 113, 210, 222 |
13 |
ACE
| 6件: Renin-angiotensin system Renin-angiotensin system 💬, Renin secretion 💬, Chagas disease 💬, Coronavirus disease - COVID-19 💬, Hypertrophic cardiomyopathy 💬, Diabetic cardiomyopathy 💬 | D03752
D03752
|
Quinapril
| 1件: 19 19 |
14 |
ACE
| 6件: Renin-angiotensin system Renin-angiotensin system 💬, Renin secretion 💬, Chagas disease 💬, Coronavirus disease - COVID-19 💬, Hypertrophic cardiomyopathy 💬, Diabetic cardiomyopathy 💬 | D07892
D07892
|
Enalapril
| 6件: 19 19, 46, 66, 113, 210, 222 |
15 |
ACE
| 6件: Renin-angiotensin system Renin-angiotensin system 💬, Renin secretion 💬, Chagas disease 💬, Coronavirus disease - COVID-19 💬, Hypertrophic cardiomyopathy 💬, Diabetic cardiomyopathy 💬 | D08131
D08131
|
Lisinopril
| 7件: 19 19, 46, 49, 66, 67, 113, 222 |
16 |
DHFR
| 5件: One carbon pool by folate One carbon pool by folate 💬, Folate biosynthesis 💬, Metabolic pathways 💬, Biosynthesis of cofactors 💬, Antifolate resistance 💬 | D00142
D00142
|
Methotrexate
| 38件: 11 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 |
17 |
DHFR
| 5件: One carbon pool by folate One carbon pool by folate 💬, Folate biosynthesis 💬, Metabolic pathways 💬, Biosynthesis of cofactors 💬, Antifolate resistance 💬 | D02115
D02115
|
Methotrexate
| 38件: 11 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 |
18 |
NQO1
| 7件: Ubiquinone and other terpenoid-quinone biosynthesis Ubiquinone and other terpenoid-quinone biosynthesis 💬, Metabolic pathways 💬, Biosynthesis of cofactors 💬, Pathways in cancer 💬, Chemical carcinogenesis - reactive oxygen species 💬, Hepatocellular carcinoma 💬, Fluid shear stress and atherosclerosis 💬 | D00564
D00564
|
Warfarin
| 13件: 6 6, 8, 13, 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 |
19 |
NQO1
| 7件: Ubiquinone and other terpenoid-quinone biosynthesis Ubiquinone and other terpenoid-quinone biosynthesis 💬, Metabolic pathways 💬, Biosynthesis of cofactors 💬, Pathways in cancer 💬, Chemical carcinogenesis - reactive oxygen species 💬, Hepatocellular carcinoma 💬, Fluid shear stress and atherosclerosis 💬 | D01280
D01280
|
Warfarin
| 13件: 6 6, 8, 13, 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 |
20 |
NQO1
| 7件: Ubiquinone and other terpenoid-quinone biosynthesis Ubiquinone and other terpenoid-quinone biosynthesis 💬, Metabolic pathways 💬, Biosynthesis of cofactors 💬, Pathways in cancer 💬, Chemical carcinogenesis - reactive oxygen species 💬, Hepatocellular carcinoma 💬, Fluid shear stress and atherosclerosis 💬 | D08682
D08682
|
Warfarin
| 13件: 6 6, 8, 13, 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 |
21 |
AGTR1
| 16件: Calcium signaling pathway Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, Phospholipase D signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Adrenergic signaling in cardiomyocytes 💬, Vascular smooth muscle contraction 💬, Apelin signaling pathway 💬, Renin-angiotensin system 💬, Renin secretion 💬, Aldosterone synthesis and secretion 💬, Cortisol synthesis and secretion 💬, AGE-RAGE signaling pathway in diabetic complications 💬, Cushing syndrome 💬, Coronavirus disease - COVID-19 💬, Pathways in cancer 💬, Diabetic cardiomyopathy 💬 | D00150
D00150
|
Angiotensin II
| 7件: 17 17, 19, 46, 66, 86, 222, 224 |
22 |
AGTR1
| 16件: Calcium signaling pathway Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, Phospholipase D signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Adrenergic signaling in cardiomyocytes 💬, Vascular smooth muscle contraction 💬, Apelin signaling pathway 💬, Renin-angiotensin system 💬, Renin secretion 💬, Aldosterone synthesis and secretion 💬, Cortisol synthesis and secretion 💬, AGE-RAGE signaling pathway in diabetic complications 💬, Cushing syndrome 💬, Coronavirus disease - COVID-19 💬, Pathways in cancer 💬, Diabetic cardiomyopathy 💬 | D00357
D00357
|
Losartan
| 18件: 17 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
23 |
AGTR1
| 16件: Calcium signaling pathway Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, Phospholipase D signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Adrenergic signaling in cardiomyocytes 💬, Vascular smooth muscle contraction 💬, Apelin signaling pathway 💬, Renin-angiotensin system 💬, Renin secretion 💬, Aldosterone synthesis and secretion 💬, Cortisol synthesis and secretion 💬, AGE-RAGE signaling pathway in diabetic complications 💬, Cushing syndrome 💬, Coronavirus disease - COVID-19 💬, Pathways in cancer 💬, Diabetic cardiomyopathy 💬 | D02014
D02014
|
Angiotensin II
| 7件: 17 17, 19, 46, 66, 86, 222, 224 |
24 |
AGTR1
| 16件: Calcium signaling pathway Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, Phospholipase D signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Adrenergic signaling in cardiomyocytes 💬, Vascular smooth muscle contraction 💬, Apelin signaling pathway 💬, Renin-angiotensin system 💬, Renin secretion 💬, Aldosterone synthesis and secretion 💬, Cortisol synthesis and secretion 💬, AGE-RAGE signaling pathway in diabetic complications 💬, Cushing syndrome 💬, Coronavirus disease - COVID-19 💬, Pathways in cancer 💬, Diabetic cardiomyopathy 💬 | D08146
D08146
|
Losartan
| 18件: 17 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
25 |
AGTR2
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Adrenergic signaling in cardiomyocytes 💬, Renin-angiotensin system 💬 | D00150
D00150
|
Angiotensin II
| 7件: 17 17, 19, 46, 66, 86, 222, 224 |
26 |
AGTR2
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Adrenergic signaling in cardiomyocytes 💬, Renin-angiotensin system 💬 | D02014
D02014
|
Angiotensin II
| 7件: 17 17, 19, 46, 66, 86, 222, 224 |
27 |
DHFR2
| 5件: One carbon pool by folate One carbon pool by folate 💬, Folate biosynthesis 💬, Metabolic pathways 💬, Biosynthesis of cofactors 💬, Antifolate resistance 💬 | D00142
D00142
|
Methotrexate
| 38件: 11 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 |
28 |
DHFR2
| 5件: One carbon pool by folate One carbon pool by folate 💬, Folate biosynthesis 💬, Metabolic pathways 💬, Biosynthesis of cofactors 💬, Antifolate resistance 💬 | D02115
D02115
|
Methotrexate
| 38件: 11 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 |
29 |
FDPS
| 4件: Terpenoid backbone biosynthesis Terpenoid backbone biosynthesis 💬, Metabolic pathways 💬, Influenza A 💬, Human T-cell leukemia virus 1 infection 💬 | D00939
D00939
|
Alendronic acid
| 7件: 19 19, 41, 46, 50, 271, 274, 299 |
30 |
FDPS
| 4件: Terpenoid backbone biosynthesis Terpenoid backbone biosynthesis 💬, Metabolic pathways 💬, Influenza A 💬, Human T-cell leukemia virus 1 infection 💬 | D07119
D07119
|
Alendronic acid
| 7件: 19 19, 41, 46, 50, 271, 274, 299 |
31 |
POLA2
| 1件: DNA replication DNA replication 💬 | D03546
D03546
|
Clofarabine
| 9件: 19 19, 20, 40, 46, 49, 60, 96, 234, 326 |
32 |
MTOR
| 51件: EGFR tyrosine kinase inhibitor resistance EGFR tyrosine kinase inhibitor resistance 💬, Endocrine resistance 💬, ErbB signaling pathway 💬, HIF-1 signaling pathway 💬, Phospholipase D signaling pathway 💬, Autophagy - other 💬, Autophagy - animal 💬, mTOR signaling pathway 💬, PI3K-Akt signaling pathway 💬, AMPK signaling pathway 💬, Longevity regulating pathway 💬, Longevity regulating pathway - multiple species 💬, Cellular senescence 💬, Apelin signaling pathway 💬, Neutrophil extracellular trap formation 💬, JAK-STAT signaling pathway 💬, Th17 cell differentiation 💬, Thermogenesis 💬, Insulin signaling pathway 💬, Thyroid hormone signaling pathway 💬, Adipocytokine signaling pathway 💬, Type II diabetes mellitus 💬, Insulin resistance 💬, Growth hormone synthesis, secretion and action 💬, Alzheimer disease 💬, Amyotrophic lateral sclerosis 💬, Huntington disease 💬, Spinocerebellar ataxia 💬, Pathways of neurodegeneration - multiple diseases 💬, Shigellosis 💬, Human cytomegalovirus infection 💬, Human papillomavirus infection 💬, Kaposi sarcoma-associated herpesvirus infection 💬, Herpes simplex virus 1 infection 💬, Human immunodeficiency virus 1 infection 💬, Pathways in cancer 💬, Proteoglycans in cancer 💬, MicroRNAs in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Colorectal cancer 💬, Pancreatic cancer 💬, Glioma 💬, Prostate cancer 💬, Acute myeloid leukemia 💬, Breast cancer 💬, Hepatocellular carcinoma 💬, Gastric cancer 💬, Central carbon metabolism in cancer 💬, Choline metabolism in cancer 💬, PD-L1 expression and PD-1 checkpoint pathway in cancer 💬, Diabetic cardiomyopathy 💬 | D00753
D00753
|
Sirolimus
| 41件: 2 2, 6, 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
33 |
GALNS
| 3件: Glycosaminoglycan degradation Glycosaminoglycan degradation 💬, Metabolic pathways 💬, Lysosome 💬 | D10333
D10333
|
Elosulfase alfa
| 1件: 19 19 |
34 |
GBA
| 4件: Other glycan degradation Other glycan degradation 💬, Sphingolipid metabolism 💬, Metabolic pathways 💬, Lysosome 💬 | D02810
D02810
|
Alglucerase
| 1件: 19 19 |
35 |
GBA
| 4件: Other glycan degradation Other glycan degradation 💬, Sphingolipid metabolism 💬, Metabolic pathways 💬, Lysosome 💬 | D03020
D03020
|
Imiglucerase
| 1件: 19 19 |
36 |
GBA
| 4件: Other glycan degradation Other glycan degradation 💬, Sphingolipid metabolism 💬, Metabolic pathways 💬, Lysosome 💬 | D09029
D09029
|
Velaglucerase alfa
| 1件: 19 19 |
37 |
GBA
| 4件: Other glycan degradation Other glycan degradation 💬, Sphingolipid metabolism 💬, Metabolic pathways 💬, Lysosome 💬 | D09675
D09675
|
Taliglucerase alfa
| 1件: 19 19 |
38 |
GHR
| 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬, Neuroactive ligand-receptor interaction 💬, PI3K-Akt signaling pathway 💬, JAK-STAT signaling pathway 💬, Growth hormone synthesis, secretion and action 💬 | D02691
D02691
|
Somatotropin
| 23件: 2 2, 3, 13, 19, 46, 65, 74, 75, 76, 78, 96, 107, 113, 187, 191, 193, 195, 236, 238, 265, 274, 276, 299 |
39 |
GLA
| 6件: Galactose metabolism Galactose metabolism 💬, Glycerolipid metabolism 💬, Sphingolipid metabolism 💬, Glycosphingolipid biosynthesis - globo and isoglobo series 💬, Metabolic pathways 💬, Lysosome 💬 | D02784
D02784
|
Agalsidase alfa
| 1件: 19 19 |
40 |
GLA
| 6件: Galactose metabolism Galactose metabolism 💬, Glycerolipid metabolism 💬, Sphingolipid metabolism 💬, Glycosphingolipid biosynthesis - globo and isoglobo series 💬, Metabolic pathways 💬, Lysosome 💬 | D03228
D03228
|
Agalsidase beta
| 1件: 19 19 |
41 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D00407
D00407
|
Methylprednisolone
| 42件: 19 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300 |
42 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D00473
D00473
|
Prednisone
| 43件: 19 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 127, 162, 164, 205, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 |
43 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D00751
D00751
|
Methylprednisolone
| 42件: 19 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300 |
44 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D00979
D00979
|
Methylprednisolone
| 42件: 19 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300 |
45 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D05000
D05000
|
Methylprednisolone
| 42件: 19 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300 |
46 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D05001
D05001
|
Methylprednisolone
| 42件: 19 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300 |
47 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D05002
D05002
|
Methylprednisolone
| 42件: 19 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300 |
48 |
GUSB
| 8件: Pentose and glucuronate interconversions Pentose and glucuronate interconversions 💬, Ascorbate and aldarate metabolism 💬, Glycosaminoglycan degradation 💬, Porphyrin metabolism 💬, Drug metabolism - other enzymes 💬, Metabolic pathways 💬, Biosynthesis of cofactors 💬, Lysosome 💬 | D11004
D11004
|
Vestronidase alfa
| 1件: 19 19 |
49 |
HDAC1
| 15件: Cell cycle Cell cycle 💬, Longevity regulating pathway - multiple species 💬, Notch signaling pathway 💬, Neutrophil extracellular trap formation 💬, Thyroid hormone signaling pathway 💬, Huntington disease 💬, Amphetamine addiction 💬, Alcoholism 💬, Human papillomavirus infection 💬, Epstein-Barr virus infection 💬, Pathways in cancer 💬, Transcriptional misregulation in cancer 💬, Viral carcinogenesis 💬, MicroRNAs in cancer 💬, Chronic myeloid leukemia 💬 | D06320
D06320
|
Vorinostat
| 3件: 19 19, 75, 96 |
50 |
HDAC2
| 15件: Cell cycle Cell cycle 💬, Longevity regulating pathway - multiple species 💬, Notch signaling pathway 💬, Neutrophil extracellular trap formation 💬, Thyroid hormone signaling pathway 💬, Huntington disease 💬, Amphetamine addiction 💬, Alcoholism 💬, Human papillomavirus infection 💬, Epstein-Barr virus infection 💬, Pathways in cancer 💬, Transcriptional misregulation in cancer 💬, Viral carcinogenesis 💬, MicroRNAs in cancer 💬, Chronic myeloid leukemia 💬 | D06320
D06320
|
Vorinostat
| 3件: 19 19, 75, 96 |
51 |
IDS
| 3件: Glycosaminoglycan degradation Glycosaminoglycan degradation 💬, Metabolic pathways 💬, Lysosome 💬 | D04499
D04499
|
Idursulfase
| 1件: 19 19 |
52 |
IDS
| 3件: Glycosaminoglycan degradation Glycosaminoglycan degradation 💬, Metabolic pathways 💬, Lysosome 💬 | D11025
D11025
|
Idursulfase beta
| 1件: 19 19 |
53 |
IDS
| 3件: Glycosaminoglycan degradation Glycosaminoglycan degradation 💬, Metabolic pathways 💬, Lysosome 💬 | D11812
D11812
|
Pabinafusp alfa
| 1件: 19 19 |
54 |
IDUA
| 3件: Glycosaminoglycan degradation Glycosaminoglycan degradation 💬, Metabolic pathways 💬, Lysosome 💬 | D04670
D04670
|
Laronidase
| 2件: 19 19, 256 |
55 |
IL1R1
| 13件: MAPK signaling pathway MAPK signaling pathway 💬, Cytokine-cytokine receptor interaction 💬, NF-kappa B signaling pathway 💬, Osteoclast differentiation 💬, Hematopoietic cell lineage 💬, Th17 cell differentiation 💬, Inflammatory mediator regulation of TRP channels 💬, Pathogenic Escherichia coli infection 💬, Shigellosis 💬, Amoebiasis 💬, Human cytomegalovirus infection 💬, Human T-cell leukemia virus 1 infection 💬, Fluid shear stress and atherosclerosis 💬 | D02934
D02934
|
Anakinra
| 19件: 2 2, 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 |
56 |
IMPDH1
| 3件: Purine metabolism Purine metabolism 💬, Drug metabolism - other enzymes 💬, Metabolic pathways 💬 | D00752
D00752
|
Mycophenolate mofetil
| 34件: 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 |
57 |
IMPDH1
| 3件: Purine metabolism Purine metabolism 💬, Drug metabolism - other enzymes 💬, Metabolic pathways 💬 | D05094
D05094
|
Mycophenolate mofetil
| 34件: 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 |
58 |
IMPDH1
| 3件: Purine metabolism Purine metabolism 💬, Drug metabolism - other enzymes 💬, Metabolic pathways 💬 | D05095
D05095
|
Mycophenolate mofetil
| 34件: 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 |
59 |
IMPDH1
| 3件: Purine metabolism Purine metabolism 💬, Drug metabolism - other enzymes 💬, Metabolic pathways 💬 | D05096
D05096
|
Mycophenolic acid
| 36件: 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 |
60 |
IMPDH2
| 3件: Purine metabolism Purine metabolism 💬, Drug metabolism - other enzymes 💬, Metabolic pathways 💬 | D00752
D00752
|
Mycophenolate mofetil
| 34件: 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 |
61 |
IMPDH2
| 3件: Purine metabolism Purine metabolism 💬, Drug metabolism - other enzymes 💬, Metabolic pathways 💬 | D05094
D05094
|
Mycophenolate mofetil
| 34件: 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 |
62 |
IMPDH2
| 3件: Purine metabolism Purine metabolism 💬, Drug metabolism - other enzymes 💬, Metabolic pathways 💬 | D05095
D05095
|
Mycophenolate mofetil
| 34件: 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 |
63 |
IMPDH2
| 3件: Purine metabolism Purine metabolism 💬, Drug metabolism - other enzymes 💬, Metabolic pathways 💬 | D05096
D05096
|
Mycophenolic acid
| 36件: 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 |
64 |
LIPA
| 3件: Steroid biosynthesis Steroid biosynthesis 💬, Lysosome 💬, Cholesterol metabolism 💬 | D10377
D10377
|
Sebelipase alfa
| 1件: 19 19 |
65 |
ARSB
| 3件: Glycosaminoglycan degradation Glycosaminoglycan degradation 💬, Metabolic pathways 💬, Lysosome 💬 | D06565
D06565
|
Galsulfase
| 1件: 19 19 |
66 |
MAN2B1
| 2件: Other glycan degradation Other glycan degradation 💬, Lysosome 💬 | D11024
D11024
|
Velmanase alfa
| 1件: 19 19 |
67 |
HDAC7
| 3件: Neutrophil extracellular trap formation Neutrophil extracellular trap formation 💬, Alcoholism 💬, Viral carcinogenesis 💬 | D06320
D06320
|
Vorinostat
| 3件: 19 19, 75, 96 |
68 |
POLA1
| 1件: DNA replication DNA replication 💬 | D03546
D03546
|
Clofarabine
| 9件: 19 19, 20, 40, 46, 49, 60, 96, 234, 326 |
69 |
PPP3CA
| 33件: MAPK signaling pathway MAPK signaling pathway 💬, Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, Oocyte meiosis 💬, Cellular senescence 💬, Wnt signaling pathway 💬, Axon guidance 💬, VEGF signaling pathway 💬, Osteoclast differentiation 💬, C-type lectin receptor signaling pathway 💬, Natural killer cell mediated cytotoxicity 💬, Th1 and Th2 cell differentiation 💬, Th17 cell differentiation 💬, T cell receptor signaling pathway 💬, B cell receptor signaling pathway 💬, Long-term potentiation 💬, Glutamatergic synapse 💬, Dopaminergic synapse 💬, Oxytocin signaling pathway 💬, Glucagon signaling pathway 💬, Renin secretion 💬, Alzheimer disease 💬, Amyotrophic lateral sclerosis 💬, Prion disease 💬, Pathways of neurodegeneration - multiple diseases 💬, Amphetamine addiction 💬, Tuberculosis 💬, Human cytomegalovirus infection 💬, Human T-cell leukemia virus 1 infection 💬, Kaposi sarcoma-associated herpesvirus infection 💬, Human immunodeficiency virus 1 infection 💬, PD-L1 expression and PD-1 checkpoint pathway in cancer 💬, Lipid and atherosclerosis 💬 | D00184
D00184
|
Cyclosporine
| 44件: 11 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
70 |
PPP3CB
| 33件: MAPK signaling pathway MAPK signaling pathway 💬, Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, Oocyte meiosis 💬, Cellular senescence 💬, Wnt signaling pathway 💬, Axon guidance 💬, VEGF signaling pathway 💬, Osteoclast differentiation 💬, C-type lectin receptor signaling pathway 💬, Natural killer cell mediated cytotoxicity 💬, Th1 and Th2 cell differentiation 💬, Th17 cell differentiation 💬, T cell receptor signaling pathway 💬, B cell receptor signaling pathway 💬, Long-term potentiation 💬, Glutamatergic synapse 💬, Dopaminergic synapse 💬, Oxytocin signaling pathway 💬, Glucagon signaling pathway 💬, Renin secretion 💬, Alzheimer disease 💬, Amyotrophic lateral sclerosis 💬, Prion disease 💬, Pathways of neurodegeneration - multiple diseases 💬, Amphetamine addiction 💬, Tuberculosis 💬, Human cytomegalovirus infection 💬, Human T-cell leukemia virus 1 infection 💬, Kaposi sarcoma-associated herpesvirus infection 💬, Human immunodeficiency virus 1 infection 💬, PD-L1 expression and PD-1 checkpoint pathway in cancer 💬, Lipid and atherosclerosis 💬 | D00184
D00184
|
Cyclosporine
| 44件: 11 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
71 |
PPP3CC
| 33件: MAPK signaling pathway MAPK signaling pathway 💬, Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, Oocyte meiosis 💬, Cellular senescence 💬, Wnt signaling pathway 💬, Axon guidance 💬, VEGF signaling pathway 💬, Osteoclast differentiation 💬, C-type lectin receptor signaling pathway 💬, Natural killer cell mediated cytotoxicity 💬, Th1 and Th2 cell differentiation 💬, Th17 cell differentiation 💬, T cell receptor signaling pathway 💬, B cell receptor signaling pathway 💬, Long-term potentiation 💬, Glutamatergic synapse 💬, Dopaminergic synapse 💬, Oxytocin signaling pathway 💬, Glucagon signaling pathway 💬, Renin secretion 💬, Alzheimer disease 💬, Amyotrophic lateral sclerosis 💬, Prion disease 💬, Pathways of neurodegeneration - multiple diseases 💬, Amphetamine addiction 💬, Tuberculosis 💬, Human cytomegalovirus infection 💬, Human T-cell leukemia virus 1 infection 💬, Kaposi sarcoma-associated herpesvirus infection 💬, Human immunodeficiency virus 1 infection 💬, PD-L1 expression and PD-1 checkpoint pathway in cancer 💬, Lipid and atherosclerosis 💬 | D00184
D00184
|
Cyclosporine
| 44件: 11 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
72 |
PPP3R1
| 32件: MAPK signaling pathway MAPK signaling pathway 💬, Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, Oocyte meiosis 💬, Cellular senescence 💬, Wnt signaling pathway 💬, Axon guidance 💬, VEGF signaling pathway 💬, Osteoclast differentiation 💬, C-type lectin receptor signaling pathway 💬, Natural killer cell mediated cytotoxicity 💬, Th1 and Th2 cell differentiation 💬, Th17 cell differentiation 💬, T cell receptor signaling pathway 💬, B cell receptor signaling pathway 💬, Long-term potentiation 💬, Glutamatergic synapse 💬, Oxytocin signaling pathway 💬, Glucagon signaling pathway 💬, Renin secretion 💬, Alzheimer disease 💬, Amyotrophic lateral sclerosis 💬, Prion disease 💬, Pathways of neurodegeneration - multiple diseases 💬, Amphetamine addiction 💬, Tuberculosis 💬, Human cytomegalovirus infection 💬, Human T-cell leukemia virus 1 infection 💬, Kaposi sarcoma-associated herpesvirus infection 💬, Human immunodeficiency virus 1 infection 💬, PD-L1 expression and PD-1 checkpoint pathway in cancer 💬, Lipid and atherosclerosis 💬 | D00184
D00184
|
Cyclosporine
| 44件: 11 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
73 |
PPP3R2
| 32件: MAPK signaling pathway MAPK signaling pathway 💬, Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, Oocyte meiosis 💬, Cellular senescence 💬, Wnt signaling pathway 💬, Axon guidance 💬, VEGF signaling pathway 💬, Osteoclast differentiation 💬, C-type lectin receptor signaling pathway 💬, Natural killer cell mediated cytotoxicity 💬, Th1 and Th2 cell differentiation 💬, Th17 cell differentiation 💬, T cell receptor signaling pathway 💬, B cell receptor signaling pathway 💬, Long-term potentiation 💬, Glutamatergic synapse 💬, Oxytocin signaling pathway 💬, Glucagon signaling pathway 💬, Renin secretion 💬, Alzheimer disease 💬, Amyotrophic lateral sclerosis 💬, Prion disease 💬, Pathways of neurodegeneration - multiple diseases 💬, Amphetamine addiction 💬, Tuberculosis 💬, Human cytomegalovirus infection 💬, Human T-cell leukemia virus 1 infection 💬, Kaposi sarcoma-associated herpesvirus infection 💬, Human immunodeficiency virus 1 infection 💬, PD-L1 expression and PD-1 checkpoint pathway in cancer 💬, Lipid and atherosclerosis 💬 | D00184
D00184
|
Cyclosporine
| 44件: 11 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
74 |
CACNA2D3
| 7件: MAPK signaling pathway MAPK signaling pathway 💬, Cardiac muscle contraction 💬, Adrenergic signaling in cardiomyocytes 💬, Oxytocin signaling pathway 💬, Hypertrophic cardiomyopathy 💬, Arrhythmogenic right ventricular cardiomyopathy 💬, Dilated cardiomyopathy 💬 | D00332
D00332
|
Gabapentin
| 5件: 6 6, 13, 19, 70, 298 |
75 |
HDAC8
| 3件: Neutrophil extracellular trap formation Neutrophil extracellular trap formation 💬, Alcoholism 💬, Viral carcinogenesis 💬 | D06320
D06320
|
Vorinostat
| 3件: 19 19, 75, 96 |
76 |
RRM1
| 5件: Purine metabolism Purine metabolism 💬, Pyrimidine metabolism 💬, Glutathione metabolism 💬, Drug metabolism - other enzymes 💬, Metabolic pathways 💬 | D01907
D01907
|
Fludarabine
| 19件: 13 13, 19, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 286, 326 |
77 |
RRM1
| 5件: Purine metabolism Purine metabolism 💬, Pyrimidine metabolism 💬, Glutathione metabolism 💬, Drug metabolism - other enzymes 💬, Metabolic pathways 💬 | D03546
D03546
|
Clofarabine
| 9件: 19 19, 20, 40, 46, 49, 60, 96, 234, 326 |
78 |
RRM1
| 5件: Purine metabolism Purine metabolism 💬, Pyrimidine metabolism 💬, Glutathione metabolism 💬, Drug metabolism - other enzymes 💬, Metabolic pathways 💬 | D07966
D07966
|
Fludarabine
| 19件: 13 13, 19, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 286, 326 |
79 |
RRM2
| 6件: Purine metabolism Purine metabolism 💬, Pyrimidine metabolism 💬, Glutathione metabolism 💬, Drug metabolism - other enzymes 💬, Metabolic pathways 💬, p53 signaling pathway 💬 | D00341
D00341
|
Hydroxyurea
| 8件: 3 3, 13, 19, 20, 65, 85, 86, 284 |
80 |
SLC6A1
| 2件: Synaptic vesicle cycle Synaptic vesicle cycle 💬, GABAergic synapse 💬 | D00332
D00332
|
Gabapentin
| 5件: 6 6, 13, 19, 70, 298 |
81 |
SMPD1
| 5件: Sphingolipid metabolism Sphingolipid metabolism 💬, Metabolic pathways 💬, Sphingolipid signaling pathway 💬, Lysosome 💬, Necroptosis 💬 | D10820
D10820
|
Olipudase alfa
| 1件: 19 19 |
82 |
TFRC
| 5件: HIF-1 signaling pathway HIF-1 signaling pathway 💬, Endocytosis 💬, Phagosome 💬, Ferroptosis 💬, Hematopoietic cell lineage 💬 | D11812
D11812
|
Pabinafusp alfa
| 1件: 19 19 |
83 |
THRA
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Thyroid hormone signaling pathway 💬 | D01010
D01010
|
Levothyroxine
| 5件: 19 19, 49, 78, 80, 222 |
84 |
THRA
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Thyroid hormone signaling pathway 💬 | D08125
D08125
|
Levothyroxine
| 5件: 19 19, 49, 78, 80, 222 |
85 |
THRB
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Thyroid hormone signaling pathway 💬 | D01010
D01010
|
Levothyroxine
| 5件: 19 19, 49, 78, 80, 222 |
86 |
THRB
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Thyroid hormone signaling pathway 💬 | D08125
D08125
|
Levothyroxine
| 5件: 19 19, 49, 78, 80, 222 |
87 |
TNF
| 67件: Antifolate resistance Antifolate resistance 💬, MAPK signaling pathway 💬, Cytokine-cytokine receptor interaction 💬, Viral protein interaction with cytokine and cytokine receptor 💬, NF-kappa B signaling pathway 💬, Sphingolipid signaling pathway 💬, mTOR signaling pathway 💬, Apoptosis 💬, Necroptosis 💬, TGF-beta signaling pathway 💬, Osteoclast differentiation 💬, Antigen processing and presentation 💬, Toll-like receptor signaling pathway 💬, NOD-like receptor signaling pathway 💬, RIG-I-like receptor signaling pathway 💬, C-type lectin receptor signaling pathway 💬, Hematopoietic cell lineage 💬, Natural killer cell mediated cytotoxicity 💬, IL-17 signaling pathway 💬, T cell receptor signaling pathway 💬, Fc epsilon RI signaling pathway 💬, TNF signaling pathway 💬, Adipocytokine signaling pathway 💬, Type II diabetes mellitus 💬, Insulin resistance 💬, Non-alcoholic fatty liver disease 💬, AGE-RAGE signaling pathway in diabetic complications 💬, Alcoholic liver disease 💬, Type I diabetes mellitus 💬, Alzheimer disease 💬, Amyotrophic lateral sclerosis 💬, Prion disease 💬, Pathways of neurodegeneration - multiple diseases 💬, Pathogenic Escherichia coli infection 💬, Shigellosis 💬, Salmonella infection 💬, Pertussis 💬, Legionellosis 💬, Yersinia infection 💬, Leishmaniasis 💬, Chagas disease 💬, African trypanosomiasis 💬, Malaria 💬, Toxoplasmosis 💬, Amoebiasis 💬, Tuberculosis 💬, Hepatitis C 💬, Hepatitis B 💬, Human cytomegalovirus infection 💬, Influenza A 💬, Human papillomavirus infection 💬, Human T-cell leukemia virus 1 infection 💬, Herpes simplex virus 1 infection 💬, Epstein-Barr virus infection 💬, Human immunodeficiency virus 1 infection 💬, Coronavirus disease - COVID-19 💬, Proteoglycans in cancer 💬, Asthma 💬, Inflammatory bowel disease 💬, Systemic lupus erythematosus 💬, Rheumatoid arthritis 💬, Allograft rejection 💬, Graft-versus-host disease 💬, Hypertrophic cardiomyopathy 💬, Dilated cardiomyopathy 💬, Lipid and atherosclerosis 💬, Fluid shear stress and atherosclerosis 💬 | D02597
D02597
|
Adalimumab
| 18件: 19 19, 37, 40, 41, 46, 56, 84, 96, 97, 107, 151, 160, 164, 222, 226, 269, 270, 271 |
88 |
UGCG
| 2件: Sphingolipid metabolism Sphingolipid metabolism 💬, Metabolic pathways 💬 | D05032
D05032
|
Miglustat
| 3件: 19 19, 256, 299 |
89 |
UGCG
| 2件: Sphingolipid metabolism Sphingolipid metabolism 💬, Metabolic pathways 💬 | D09893
D09893
|
Eliglustat
| 1件: 19 19 |
90 |
UGCG
| 2件: Sphingolipid metabolism Sphingolipid metabolism 💬, Metabolic pathways 💬 | D11439
D11439
|
Lucerastat
| 1件: 19 19 |
91 |
UGCG
| 2件: Sphingolipid metabolism Sphingolipid metabolism 💬, Metabolic pathways 💬 | D11633
D11633
|
Venglustat
| 3件: 6 6, 19, 67 |
92 |
VDR
| 5件: Parathyroid hormone synthesis, secretion and action Parathyroid hormone synthesis, secretion and action 💬, Endocrine and other factor-regulated calcium reabsorption 💬, Mineral absorption 💬, Tuberculosis 💬, Chemical carcinogenesis - receptor activation 💬 | D00188
D00188
|
Cholecalciferol
| 25件: 6 6, 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 60, 65, 75, 84, 85, 96, 97, 98, 162, 202, 228, 271, 298, 299 |
93 |
VDR
| 5件: Parathyroid hormone synthesis, secretion and action Parathyroid hormone synthesis, secretion and action 💬, Endocrine and other factor-regulated calcium reabsorption 💬, Mineral absorption 💬, Tuberculosis 💬, Chemical carcinogenesis - receptor activation 💬 | D00930
D00930
|
Paricalcitol
| 4件: 19 19, 66, 218, 238 |
94 |
TRPV1
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Inflammatory mediator regulation of TRP channels 💬 | D00250
D00250
|
Capsaicin
| 5件: 2 2, 6, 19, 86, 226 |
95 |
CACNA2D1
| 7件: MAPK signaling pathway MAPK signaling pathway 💬, Cardiac muscle contraction 💬, Adrenergic signaling in cardiomyocytes 💬, Oxytocin signaling pathway 💬, Hypertrophic cardiomyopathy 💬, Arrhythmogenic right ventricular cardiomyopathy 💬, Dilated cardiomyopathy 💬 | D00332
D00332
|
Gabapentin
| 5件: 6 6, 13, 19, 70, 298 |
96 |
IL1R2
| 7件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬, Hematopoietic cell lineage 💬, Amoebiasis 💬, Human T-cell leukemia virus 1 infection 💬, Transcriptional misregulation in cancer 💬, Prostate cancer 💬, Fluid shear stress and atherosclerosis 💬 | D02934
D02934
|
Anakinra
| 19件: 2 2, 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 |
97 |
CXCR4
| 12件: Calcium signaling pathway Calcium signaling pathway 💬, Cytokine-cytokine receptor interaction 💬, Viral protein interaction with cytokine and cytokine receptor 💬, Chemokine signaling pathway 💬, Endocytosis 💬, Axon guidance 💬, Leukocyte transendothelial migration 💬, Intestinal immune network for IgA production 💬, Regulation of actin cytoskeleton 💬, Human cytomegalovirus infection 💬, Human immunodeficiency virus 1 infection 💬, Pathways in cancer 💬 | D08971
D08971
|
Plerixafor
| 6件: 19 19, 20, 51, 65, 285, 299 |
98 |
VKORC1
| 3件: Ubiquinone and other terpenoid-quinone biosynthesis Ubiquinone and other terpenoid-quinone biosynthesis 💬, Metabolic pathways 💬, Biosynthesis of cofactors 💬 | D00564
D00564
|
Warfarin
| 13件: 6 6, 8, 13, 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 |
99 |
VKORC1
| 3件: Ubiquinone and other terpenoid-quinone biosynthesis Ubiquinone and other terpenoid-quinone biosynthesis 💬, Metabolic pathways 💬, Biosynthesis of cofactors 💬 | D01280
D01280
|
Warfarin
| 13件: 6 6, 8, 13, 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 |
100 |
VKORC1
| 3件: Ubiquinone and other terpenoid-quinone biosynthesis Ubiquinone and other terpenoid-quinone biosynthesis 💬, Metabolic pathways 💬, Biosynthesis of cofactors 💬 | D08682
D08682
|
Warfarin
| 13件: 6 6, 8, 13, 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 |
101 |
HDAC11
| 3件: Neutrophil extracellular trap formation Neutrophil extracellular trap formation 💬, Alcoholism 💬, Viral carcinogenesis 💬 | D06320
D06320
|
Vorinostat
| 3件: 19 19, 75, 96 |
102 |
HDAC10
| 3件: Neutrophil extracellular trap formation Neutrophil extracellular trap formation 💬, Alcoholism 💬, Viral carcinogenesis 💬 | D06320
D06320
|
Vorinostat
| 3件: 19 19, 75, 96 |
103 |
CASP9
| 35件: Platinum drug resistance Platinum drug resistance 💬, p53 signaling pathway 💬, PI3K-Akt signaling pathway 💬, Apoptosis 💬, Apoptosis - multiple species 💬, VEGF signaling pathway 💬, Thyroid hormone signaling pathway 💬, Alzheimer disease 💬, Parkinson disease 💬, Amyotrophic lateral sclerosis 💬, Huntington disease 💬, Prion disease 💬, Pathways of neurodegeneration - multiple diseases 💬, Pathogenic Escherichia coli infection 💬, Legionellosis 💬, Toxoplasmosis 💬, Tuberculosis 💬, Hepatitis C 💬, Hepatitis B 💬, Measles 💬, Human cytomegalovirus infection 💬, Influenza A 💬, Kaposi sarcoma-associated herpesvirus infection 💬, Herpes simplex virus 1 infection 💬, Epstein-Barr virus infection 💬, Human immunodeficiency virus 1 infection 💬, |